Effect of adiponectin genetic polymorphism on rosiglitazone response
Phase of Trial: Phase III
Latest Information Update: 09 Oct 2009
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Oct 2009 Last checked against ClinicalTrials.gov record.
- 13 Aug 2007 New trial record.